Plantable Health Inc. (NEO: PLBL) is a clinically supported plant-based program that combines behavioral psychology, neuroscience, and nutritional science to transform health and wellness in just 28 days. Plantable promotes a healthy lifestyle by combining meals, personalized coaching support, and lifestyle tools for adopting and maintaining a plant-based diet. The company’s mission is to end unnecessary chronic disease, bringing joy to people’s lives through optimal health and well-being.
Launch of Digital App
On January 18, Plantable Health announced that it was expanding globally through the launch of its lifestyle app. The Plantable App, which is the company’s first expansion outside of the United States, is now available for free download via the Apple App Store or Google Play.
The Plantable App launch marks the first phase of a larger digital health initiative the company has planned and will be funded through the use of proceeds from its recent IPO financing. Plantable will continue to improve its app through product updates while striving to create a reliable and transparent technology ecosystem for all users. The growing popularity of weight loss apps and digital health platforms has accelerated due to health concerns driving global demand for lifestyle change which has been heightened during the pandemic.
“At our core, the foundation of Plantable is healthy plant-based nutrition. However, it is our supplemental coaching and technology platform that helps our clients achieve long lasting behaviour change. Our digital platform provides our clients the tools they need to become ambassadors of their own health, and permanently rewire their habits through daily interaction with our coaches and app. Advancing our technology is a key focus for our company this year, as we look to enhance our client offering, and expand into the rapidly growing digital health sector,” said Plantable Health CEO Dr. Nadja Pinnavaia.
Public Listing on NEO Exchange Following IPO
On January 12, Plantable began trading on the NEO exchange under the symbol PLBL. As part of its investor awareness program, the company has retained the services of Hybrid Financial Ltd. to provide marketing services for an initial period of 12 months. The goal is to increase Plantable‘s market and brand awareness and to expand the company’s reach within the investment community.
On December 31, Plantable completed its IPO, at a price of C$0.40 per share for gross proceeds of C$4.5 million. The company will use proceeds from the IPO for sales, marketing, clinical trials, working capital, and technology development.
Dr. Pinnavaia said that the IPO is a critical step that allows Plantable to scale its operations and support current and future clinical trials to clinically prove its effective solution for behavior change over the long term.
Accelerating Growth Profile
By the end of 2022, Plantable plans to conclude its first trials as a clinically plant-based dietary intervention program proven to reduce the risk factors associated with cancer and metabolic diseases, including inflammation, cholesterol, blood pressure, obesity, gene expression and microbiome changes.
Plantable is uniquely positioned to take advantage of market shifts and will drive success through its strong financial and operating model, designed to result in organic growth and strategic developments.
